Boehringer to Sell Pet Vaccines to Lilly

07.10.2016 - German drugmaker Boehringer Ingelheim is selling the pet vaccines portfolio of its US subsidiary Vetmedica to Eli Lilly’s animal health subsidiary Elanco for $885 million to allay...